Pharmacist Associations Partner to Increase the Voice o... ( ALEXANDRIA Va. June 9 -- The Nat...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Pharmacist Associations Partner to Increase the Voice of Pharmacy

Date:6/9/2008

ALEXANDRIA, Va., June 9 /PRNewswire-USNewswire/ -- The National Community Pharmacists Association (NCPA) and the International Academy of Compounding Pharmacists (IACP) are collaborating to increase the legislative and regulatory clout of pharmacists who engage in compounding. IACP has established a satellite office at NCPA's headquarters, which is led by their Director of Public Affairs, Sarah R. Dodge. In addition, since both groups share common concerns about federal government policies regarding pharmacy compounding, they will be able to better unite in conveying a message to elected and appointed federal officials about how patients can be hurt or helped by their pharmacy compounding decisions.

"The federal government has shown a proclivity for pursuing and adopting unwarranted and unnecessary policies when it comes to pharmacy compounding as was recently demonstrated by their arbitrary ban of estriol in compounded medications for bio-identical hormone replacement therapy," said Bruce T. Roberts, NCPA executive vice president and CEO. "NCPA and IACP are committed to joining forces whenever possible to ensure patient access to medications created through compounding is not endangered."

Besides the ongoing battle to change the Food and Drug Administration's (FDA) stance towards estriol, there are numerous other areas where NCPA and IACP have been aligned in the past and are likely to be in the future. For example, in 2007, both groups fought back three separate attempts in Congress to usurp the current responsibility of the State Boards of Pharmacies in regulating certain aspects of pharmacy compounding. Both NCPA and IACP believe the FDA should regulate new drugs and the manufacturers of new drugs, while pharmacy compounding should continue to be regulated by State Boards of Pharmacies. What was attempted last year was to have those responsibilities mixed, which would have introduced a plethora of bureaucratic inefficiencies into the health
'/>"/>

SOURCE National Community Pharmacists Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Walgreens Pays $35 Million, Settles Pharmacist-Whistleblower Qui Tam Drug Switching Allegations
2. Patients, Doctors, Pharmacists Praise Bipartisan House Resolution on Compounded Hormones Containing Estriol
3. Pharmacists Customize Prescriptions By Patient, Day and Dose with onePAC(TM) Packaging
4. Pharmacists believe drive-through windows contribute to delays, errors
5. Medcos Specialized Pharmacists, Safety Programs Gain Therapy Management Accreditation
6. Kentucky Pharmacists Urge Senator McConnell to Put Patients First
7. Kentucky Pharmacists Event Urging Senate Minority Leader McConnell to Fix Flawed Medicaid Drug Reimbursement Rule
8. The American Pharmacists Association Supports Consumer Education About OTC Medications
9. FDA Hears Pros, Cons of Pharmacist-to-Patient Drug Sales
10. FDA Mulls Direct Pharmacist-to-Patient Drug Sales
11. Pharmacists Press Conference Urging Senate Majority Leader Harry Reid to Fix Flawed Medicaid Drug Reimbursement Rule

Post Your Comments:

Breaking Medicine News(10 mins):Health News:The Flag Company, Inc.'s Recently Released “Feel Good” Light Lenses Grows Into Its Own Website 2 Health News:The Flag Company, Inc.'s Recently Released “Feel Good” Light Lenses Grows Into Its Own Website 3 Health News:Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs 2 Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 2 Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 3 Health News:VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution 2 Health News:Prostate Hormone Therapy May Up Heart Risks 2 Health News:Prostate Hormone Therapy May Up Heart Risks 3

[0] The Flag Company, Inc.'s Recently Released “Feel Good” Light Lenses Grows Into Its Own Website [1] Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs [0] Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards [1] VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution [0] Prostate Hormone Therapy May Up Heart Risks

Novel compound may lessen heart attack damage MedCath Corporation Reports First Quarter Earnings Pharmaceutical Product Commercialization & Governance Best Practices: Securing Talent for Highly-Effective Brand Teams DRAXIS Health Reports Fourth Quarter and Year End Results Can a Video Game Make Your Kids More Fit?Nuvelo Announces Upcoming Conference Calls, Webcasts and Conference Participation

[0] CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition [0] The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies [0] Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting

Other Medicine Technology:InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 2 InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 3 InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 4 Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 2 Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 3 Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 4

InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds

Medicine Products:

Stainless Steel Locking Pliers Double Action Wire Cutter optomap Retinal Examination SR - Single Rectangular Head Camera

Pharmacist Associations Partner to Increase the Voice o...( ALEXANDRIA Va. June 9 -- The Nat...),Health